Final analysis of the ECOG I-COPA trial (E6484) in patients with non-Hodgkin's lymphoma treated with interferon alfa (IFN-alpha2a) plus an anthracycline-based induction regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples